+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of pseudoisochromatic plates in the diagnosis of ethambutol induced toxic optic neuropathy



Use of pseudoisochromatic plates in the diagnosis of ethambutol induced toxic optic neuropathy



Rinsho Ganka 38(12): 1229-1233



Standard Pseudoisochromatic Plates Part 2 for Acquired Color Vision Defects (SPP-2) were used for the detection and evaluation of color vision disturbance in optic neuropathy due to ethambutol therapy. A series of 47 patients under systemic ethambutol treatment was examined using SPP-2, AO-HRR plates and Farnsworth's dichtomous test. Optic neuropathy was suspected in 11 patients, all of whom were more or less color-defective. Red-green defect was more marked than blue-yellow in mild cases. Both types of defects were involved equally in severe cases and resulted in achromatopsia. While test results with SPP-2 failed to indicate the severity of defects due to individual differences, the number of errors was fairly well correlated with the visual acuity. Apparently, color vision tests are useful in the routine screening for optic neuropathy in patients undergoing systemic ethambutol therapy. Pseudoisochromatic plates are preferred for this procedure. For acquired vision defects, SPP-2 is currently the only pseudoisochromatic plates available.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 006881050

Download citation: RISBibTeXText


Related references

Ethambutol induced toxic optic neuropathy in HIV positive patients. International Journal of Ophthalmology 6(4): 542-545, 2013

Bitemporal hemianopsia in a case of ethambutol-induced toxic optic neuropathy. Rinsho Ganka 52(5): 757-760, 1998

The role of copper on mitochondrial metabolism in patients with ethambutol-induced toxic optic neuropathy and in mycobacterial infection. Investigative Ophthalmology & Visual Science 38(4 Part 1-2): S147, 1997

Leber's hereditary optic neuropathy masquerading as ethambutol-induced optic neuropathy in a young male. Indian Journal of Ophthalmology 54(3): 218-219, 2006

The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagnostic Microbiology and Infectious Disease 30(2): 83-87, 1998

Leber's hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy. Journal of Neurology 250(1): 87-89, 2003

Ethambutol/Linezolid Toxic Optic Neuropathy. Optometry and Vision Science 93(2): 211-217, 2016

Re-Treatment With Ethambutol After Toxic Optic Neuropathy. Journal of Neuro-Ophthalmology 37(1): 40-42, 2017

Incidence of toxic optic neuropathy with low-dose ethambutol. International Journal of Tuberculosis and Lung Disease 20(2): 261-264, 2016

Toxic bilateral optic neuropathy caused by ethambutol and isoniazid. Bulletin des Societes d'Ophtalmologie de France 86(12): 1421-1422, 1986

Toxic optic neuropathy associated with ethambutol: implications for current therapy. Journal of the American Optometric Association 65(5): 332-338, 1994

Determination of potential role of antioxidative status and circulating biochemical markers in the pathogenesis of ethambutol induced toxic optic neuropathy among diabetic and non-diabetic patients. Saudi Journal of Biological Sciences 22(6): 739-743, 2015

Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy. British Journal of Ophthalmology 71(3): 192-196, 1987

An automatic display system for pseudoisochromatic plates report 1. standard pseudoisochromatic plates part 1. Rinsho Ganka 39(11): 1299-1302, 1985

Toxic optic neuropathy: Psychotropics and ethambutol inhibit myelin basic protein phosphorylation. Journal of Toxicology Cutaneous & Ocular Toxicology 18(1): 13-22, 1999